Association of Inherited Mutations in DNA Repair Genes with Localized Prostate Cancer
暂无分享,去创建一个
D. Rader | J. Weaver | S. Damrauer | S. Domchek | V. Narayan | J. Powers | R. Judy | R. Kember | A. Doucette | K. Maxwell | Daniel J Lee | L. Schwartz | R. Genetics Center | C. Morrison | A. Le | Emily Feld | H. Desai | G. Kelly | P. Gabriel | James Ding | R. Hausler | James M Ding
[1] A. D'Amico,et al. NCCN Guidelines Insights: Prostate Cancer, Version 1.2021. , 2021, Journal of the National Comprehensive Cancer Network : JNCCN.
[2] James M. Hodge,et al. A Population-Based Study of Genes Previously Implicated in Breast Cancer. , 2021, The New England journal of medicine.
[3] Alexander Hanbo Li,et al. Exome-wide evaluation of rare coding variants using electronic health records identifies new gene–phenotype associations , 2021, Nature Medicine.
[4] E. Antonarakis,et al. Practical Considerations and Challenges for Germline Genetic Testing in Patients With Prostate Cancer: Recommendations From the Germline Genetics Working Group of the PCCTC. , 2020, JCO oncology practice.
[5] C. Higano,et al. Rucaparib in Men With Metastatic Castration-Resistant Prostate Cancer Harboring a BRCA1 or BRCA2 Gene Alteration , 2020, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[6] Alexander E. Lopez,et al. Polygenic Risk of Psychiatric Disorders Exhibits Cross-trait Associations in Electronic Health Record Data From European Ancestry Individuals , 2020, Biological Psychiatry.
[7] Anne E. Calvaresi,et al. Implementation of Germline Testing for Prostate Cancer: Philadelphia Prostate Cancer Consensus Conference 2019. , 2020, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[8] Jianfeng Xu,et al. Diagnosing hereditary cancer predisposition in men with prostate cancer , 2020, Genetics in Medicine.
[9] Jonathan M. Mudge,et al. Transcript expression-aware annotation improves rare variant interpretation , 2020, Nature.
[10] F. Saad,et al. Olaparib for Metastatic Castration-Resistant Prostate Cancer. , 2020, The New England journal of medicine.
[11] F. Couch,et al. Pathogenic Variants in Cancer Predisposition Genes and Prostate Cancer Risk in Men of African Ancestry. , 2020, JCO precision oncology.
[12] Shan Yang,et al. Inherited DNA-repair gene mutations in African American men with prostate cancer , 2020, Oncotarget.
[13] K. Cooney,et al. Rare Germline Pathogenic Mutations of DNA Repair Genes Are Most Strongly Associated with Grade Group 5 Prostate Cancer. , 2020, European urology oncology.
[14] A. Jemal,et al. Cancer statistics, 2020 , 2020, CA: a cancer journal for clinicians.
[15] F. Couch,et al. Contribution of Inherited DNA-Repair Gene Mutations to Hormone-Sensitive and Castrate-Resistant Metastatic Prostate Cancer and Implications for Clinical Outcome. , 2019, JCO precision oncology.
[16] R. Eeles,et al. Germline DNA Repair Gene Mutations in Young-onset Prostate Cancer Cases in the UK: Evidence for a More Extensive Genetic Panel , 2019, European urology.
[17] Dustin N. Hartzel,et al. A genome-first approach to aggregating rare genetic variants in LMNA for association with electronic health record phenotypes , 2019, Genetics in Medicine.
[18] J. Kleijnen,et al. A systematic review of the prevalence of DNA damage response gene mutations in prostate cancer , 2019, International journal of oncology.
[19] E. Schaeffer,et al. Germline and Somatic Mutations in Prostate Cancer for the Clinician. , 2019, Journal of the National Comprehensive Cancer Network : JNCCN.
[20] A. Jemal,et al. Cancer statistics for African Americans, 2019 , 2019, CA: a cancer journal for clinicians.
[21] R. Nussbaum,et al. Prevalence of Germline Variants in Prostate Cancer and Implications for Current Genetic Testing Guidelines , 2019, JAMA oncology.
[22] Ryan L. Collins,et al. The mutational constraint spectrum quantified from variation in 141,456 humans , 2020, Nature.
[23] S. Ambs,et al. Increased frequency of germline BRCA2 mutations associates with prostate cancer metastasis in a racially diverse patient population , 2018, Prostate Cancer and Prostatic Diseases.
[24] John Garcia,et al. Germline genetic testing for inherited prostate cancer in practice: Implications for genetic testing, precision therapy, and cascade testing , 2018, The Prostate.
[25] M. Dall’Era,et al. Attitudes Toward Genomic Testing and Prostate Cancer Research Among Black Men. , 2018, American journal of preventive medicine.
[26] W. Isaacs,et al. Intraductal/ductal histology and lymphovascular invasion are associated with germline DNA‐repair gene mutations in prostate cancer , 2018, The Prostate.
[27] K. Cooney,et al. Rare germline mutations in African American men diagnosed with early‐onset prostate cancer , 2018, The Prostate.
[28] Z. Szallasi,et al. The association between germline BRCA2 variants and sensitivity to platinum‐based chemotherapy among men with metastatic prostate cancer , 2017, Cancer.
[29] Anne Lanceley,et al. Awareness, knowledge, perceptions, and attitudes towards genetic testing for cancer risk among ethnic minority groups: a systematic review , 2017, BMC Public Health.
[30] K. Cooney,et al. Germline Mutations in ATM and BRCA1/2 Distinguish Risk for Lethal and Indolent Prostate Cancer and are Associated with Early Age at Death. , 2017, European urology.
[31] S. Fullerton,et al. Genomics is failing on diversity , 2016, Nature.
[32] Ahmet Zehir,et al. Inherited DNA-Repair Gene Mutations in Men with Metastatic Prostate Cancer. , 2016, The New England journal of medicine.
[33] C. Ayo,et al. An Estimate of the Incidence of Prostate Cancer in Africa: A Systematic Review and Meta-Analysis , 2016, PloS one.
[34] G. Parmigiani,et al. Familial Risk and Heritability of Cancer Among Twins in Nordic Countries. , 2016, JAMA.
[35] L. Kiemeney,et al. Targeted Prostate Cancer Screening in BRCA1 and BRCA2 Mutation Carriers: Results from the Initial Screening Round of the IMPACT Study , 2014, European urology.
[36] J. Powers,et al. Adverse Events in Cancer Genetic Testing: The Third Case Series , 2014, Cancer journal.
[37] Alexis Criscuolo,et al. AlienTrimmer removes adapter oligonucleotides with high sensitivity in short-insert paired-end reads. Commentary on Turner (2014) Assessment of insert sizes and adapter content in FASTQ data from NexteraXT libraries , 2014, Front. Genet..
[38] D. Petersen,et al. Clinical Presentation of Prostate Cancer in Black South Africans , 2014, The Prostate.
[39] T. Sellers,et al. Modes of delivery of genetic testing services and the uptake of cancer risk management strategies in BRCA1 and BRCA2 carriers , 2014, Clinical genetics.
[40] R. Eeles,et al. Germline BRCA mutations are associated with higher risk of nodal involvement, distant metastasis, and poor survival outcomes in prostate cancer. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[41] M. DePristo,et al. The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. , 2010, Genome research.
[42] H. Hakonarson,et al. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data , 2010, Nucleic acids research.
[43] Richard Durbin,et al. Fast and accurate long-read alignment with Burrows–Wheeler transform , 2010, Bioinform..
[44] Manuel A. R. Ferreira,et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. , 2007, American journal of human genetics.
[45] D. Reich,et al. Principal components analysis corrects for stratification in genome-wide association studies , 2006, Nature Genetics.
[46] O. Olopade,et al. Disparities in genetic testing: thinking outside the BRCA box. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[47] D. Brizel,et al. National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology , 2012 .
[48] C. Boring,et al. Cancer statistics for african americans , 1992, CA: a cancer journal for clinicians.